The 12-month price targets, analyzed by analysts, offer insights with an average target of $36.85, a high estimate of $68.00, ...

The consensus estimate has shifted -18% due to these changes. At this time, Hims & Hers Health has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with an F.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. San Francisco, CA-based Hims & Hers Health, Inc. is a consumer-centric health and wellness platform that ...

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health ...

Hims & Hers Health has an analyst consensus of Hold ... In a report released today, Morgan Stanley also maintained a Hold rating on the stock with a $60.00 price target. HIMS market cap is ...

Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, citing increased uncertainty following the recent FDA ruling on weight ...